Search
for
Sort by
Research 61–90 of 1000+
- ETHNOBOTANICAL USES, PHYTOCHEMISTRY AND PHARMACOLOGICAL ACTIVITIES OF PEPEROMIA PELLUCIDA (L.) KUNTH (PIPERACEAE)-A REVIEW
- Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology
- Effect of Fenugreek Extract on Testosterone Propionate-Induced Benign Prostatic Hyperplasia
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- Effect of Marine-Derived Saccharides on Human Skin Fibroblasts and Dermal Papilla Cells
- Celiac Disease: Beyond Diet and Food Awareness
- Modulating the Antioxidant Response for Better Oxidative Stress-Inducing Therapies: How to Take Advantage of Two Sides of the Same Medal?
- Prenatal serological diagnosis of intrauterine cytomegalovirus infection.
- Is COVID-19 Gender-sensitive?
- Repurposing of approved cardiovascular drugs
- Concurrence of Palmoplantar Psoriasiform Eruptions and Hair Loss during Carbamazepine Treatment
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- Oral zinc therapy for zinc deficiency-related telogen effluvium
- Cutaneous signs in COVID ‐19 patients: A review
- Frontal fibrosing alopecia: A review of 60 cases
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Finasteride induced depression: a prospective study
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- Diagnostic approach to low‐renin hypertension
- Pathobiology questions raised by telogen effluvium and trichodynia in COVID‐19 patients
- Postpartum Alopecia
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- Cutaneous Crohn's disease treated with infliximab and 4 years of follow up
- Multiple minute digitate hyperkeratosis